Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 11/20 | 0.52 |
| ▸ | AVPR1A | P37288 | 8/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | OXTR | P30559 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7339753 | 0.81 | AVPR2 (0.57) | AVPR2AVPR1A | |
| SCHEMBL7355406 | 0.79 | AVPR2 (0.57) | AVPR2AVPR1ATP53NPC1RAB9A | |
| SCHEMBL7333936 | 0.79 | AVPR2 (0.81) | AVPR2AVPR1AOXTR | |
| SCHEMBL8312651 | 0.73 | AVPR2 (0.72) | AVPR2AVPR1AOXTR | |
| SCHEMBL8313226 | 0.72 | AVPR2 (0.70) | AVPR2AVPR1AOXTR | |
| SCHEMBL7337720 | 0.72 | AVPR2 (0.70) | AVPR2AVPR1A | |
| SCHEMBL7333306 | 0.71 | AVPR2 (0.64) | AVPR2AVPR1A | |
| SCHEMBL7331851 | 0.71 | AVPR2 (0.72) | AVPR2AVPR1A | |
| SCHEMBL8314271 | 0.71 | AVPR2 (0.81) | AVPR2AVPR1A | |
| SCHEMBL8559006 | 0.70 | AVPR2 (0.75) | AVPR2AVPR1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5516774-A | TREATING DISEASES CHARACTERIZED BY EXCESS RENAL REABSORPTION OF WATER | AMERICAN CYANAMID COMPANY (US) | 1996-05-14 | — | — | US | disclosed |